BackEpizyme Overview

Epizyme Cost of Revenue

Cost of Revenue analysis for EPZM.

Quarterly Cost of Revenue

$5.20M
108.67% YoY

As of Jun 30, 2022

Annual Cost of Revenue (TTM)

$12.95M
47.58% YoY

Trailing 12 months ending Jun 30, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)